Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04179864
Title A Phase 1b/2 Open-Label Study in Chemotherapy Naive Subjects With Metastatic Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Epizyme, Inc.

prostate small cell carcinoma

prostate neuroendocrine neoplasm

prostate adenocarcinoma


Enzalutamide + Tazemetostat

Abiraterone + Prednisone + Tazemetostat

Age Groups: adult | senior
Covered Countries USA | ESP | BEL

No variant requirements are available.